AYOXXA offers LUNARIS™, a multiplex protein analysis platform situated at the heart of a medical revolution: the decoding of the human proteome, which will help us to understand and cure most known diseases.
Proteomics will play an important part in personalized medicine that will replace the more and more outdated “one drug fits all” model with a more tailored approach.
Therefore R&D will depend on
innovative technologies for protein analysis. AYOXXA has developed such a platform, which allows to simultaneously measure large amounts of proteins and biomolecular analytes. The LUNARIS™ BioChip precisely identifies and quantifies proteins, including markers forinflammation, ophthalmology and more in mouse and human specimen.